BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9744295)

  • 1. Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS.
    Gelman IH; Lee K; Tombler E; Gordon R; Lin X
    Cell Motil Cytoskeleton; 1998; 41(1):1-17. PubMed ID: 9744295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
    Lin X; Gelman IH
    Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein.
    Xia W; Gelman IH
    Exp Cell Res; 2002 Jul; 277(2):139-51. PubMed ID: 12083796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response.
    Nelson PJ; Gelman IH
    Mol Cell Biochem; 1997 Oct; 175(1-2):233-41. PubMed ID: 9350056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture.
    Lin X; Tombler E; Nelson PJ; Ross M; Gelman IH
    J Biol Chem; 1996 Nov; 271(45):28430-8. PubMed ID: 8910468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis.
    Gelman IH; Tombler E; Vargas J
    Histochem J; 2000 Jan; 32(1):13-26. PubMed ID: 10805381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.
    Lin X; Nelson P; Gelman IH
    Mol Cell Biol; 2000 Oct; 20(19):7259-72. PubMed ID: 10982843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.
    Su B; Gao L; Meng F; Guo LW; Rothschild J; Gelman IH
    Oncogene; 2013 Apr; 32(16):2016-26. PubMed ID: 22710722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton.
    Tsuda T; Kusui T; Jensen RT
    Biochemistry; 1997 Dec; 36(51):16328-37. PubMed ID: 9405068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
    Xia W; Unger P; Miller L; Nelson J; Gelman IH
    Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.
    Gelman IH; Gao L
    Mol Cancer Res; 2006 Mar; 4(3):151-8. PubMed ID: 16547152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS.
    Lin X; Gelman IH
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1368-75. PubMed ID: 11820772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of microtubules in the control of adhesion-dependent signal transduction.
    Bershadsky A; Chausovsky A; Becker E; Lyubimova A; Geiger B
    Curr Biol; 1996 Oct; 6(10):1279-89. PubMed ID: 8939572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells.
    Nelson PJ; Moissoglu K; Vargas J; Klotman PE; Gelman IH
    J Cell Sci; 1999 Feb; 112 ( Pt 3)():361-70. PubMed ID: 9885289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.
    Su B; Bu Y; Engelberg D; Gelman IH
    J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the cytoskeleton in adhesion stabilization of human colorectal carcinoma cells to extracellular matrix components under dynamic conditions of laminar flow.
    Haier J; Nicolson GL
    Clin Exp Metastasis; 1999; 17(8):713-21. PubMed ID: 10919716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of focal adhesion kinase and mitogen-activated protein kinase tyrosine phosphorylation during insulin-like growth factor-I-mediated cytoskeletal reorganization.
    Kim B; Feldman EL
    J Neurochem; 1998 Sep; 71(3):1333-6. PubMed ID: 9721762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.
    Guo LW; Gao L; Rothschild J; Su B; Gelman IH
    J Biol Chem; 2011 Nov; 286(44):38356-38366. PubMed ID: 21903576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKC-regulated myogenesis is associated with increased tyrosine phosphorylation of FAK, Cas, and paxillin, formation of Cas-CRK complex, and JNK activation.
    Goel HL; Dey CS
    Differentiation; 2002 Aug; 70(6):257-71. PubMed ID: 12190987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL.
    Salgia R; Brunkhorst B; Pisick E; Li JL; Lo SH; Chen LB; Griffin JD
    Oncogene; 1995 Sep; 11(6):1149-55. PubMed ID: 7566975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.